Literature DB >> 25831991

The assessment of renalase: searching for the best predictor of early renal dysfunction by multivariate modeling in stable renal transplant recipients.

Dijana Stojanovic1, Tatjana Cvetkovic2, Miodrag Stojanovic3, Vladmila Bojanic1, Nikola Stefanovic4, Ivana Stojanovic2.   

Abstract

BACKGROUND: Renal transplant dysfunction has been shown to be an independent risk factor for cardiac, non-cardiovascular, and all-cause mortality in post-transplantation follow-up.
MATERIAL AND METHODS: We enrolled 73 renal transplant recipients who were more than 12 months post-renal transplant surgery, had stable graft function, and were on standard immunosuppression. The purpose of the study was to observe the relation between renal dysfunction and endothelial dysfunction parameters (nitrates, asymmetric and symmetric dimethylarginine, and endothelial nitric oxide synthase), and renalase, and to hypothesize the best predictor of early renal dysfunction by multivariate modeling. The other aim was to observe differences with regard to immunosuppression.
RESULTS: Non-adjusted odds ratio showed a significant risk of reduced glomerular filtration rate in transplant recipients with increased renalase concentration (p=0.026); age-adjusted odds ratio showed a significant risk of reduced glomerular filtration rate with increased renalase concentration (p=0.042), also after multivariable adjustment (p=0.032). Increased plasma endothelial nitric oxide synthase concentration was a protective factor for glomerular filtration rate (p=0.011). After adjustment for age (p=0.045), and after multivariate modeling, endothelial nitric oxide synthase was shown to be a protective factor for glomerular filtration rate (p=0.014). Significant differences in immunosuppression were found in plasma renalase in patients maintained on cyclosporine (p=0.027).
CONCLUSIONS: Renalase was shown to be strong predictor of decreased glomerular filtration rate and was significantly higher in the group of patients on cyclosporine. Endothelial nitric oxide synthase was identified as a strong protective factor for kidney function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25831991     DOI: 10.12659/AOT.892632

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  10 in total

Review 1.  The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis.

Authors:  Dijana Stojanovic; Valentina Mitic; Miodrag Stojanovic; Jelena Milenkovic; Aleksandra Ignjatovic; Maja Milojkovic
Journal:  Front Cardiovasc Med       Date:  2022-05-31

2.  Age influence on renalase and catecholamines concentration in hypertensive patients, including maintained dialysis.

Authors:  Edyta Zbroch; Dominika Musialowska; Ewa Koc-Zorawska; Jolanta Malyszko
Journal:  Clin Interv Aging       Date:  2016-10-28       Impact factor: 4.458

3.  The Oxidative and Inflammatory State in Patients with Acute Renal Graft Dysfunction Treated with Tacrolimus.

Authors:  Sandra Carrillo-Ibarra; José Ignacio Cerrillos-Gutiérrez; Ariadna Escalante-Núñez; Enrique Rojas-Campos; Benjamín Gómez-Navarro; Sonia Sifuentes-Franco; Ernesto Germán Cardona-Muñoz; Alejandra Guillermina Miranda-Díaz
Journal:  Oxid Med Cell Longev       Date:  2016-10-30       Impact factor: 6.543

4.  Serum Renalase Levels Are Predicted by Brain-Derived Neurotrophic Factor and Associated with Cardiovascular Events and Mortality after Percutaneous Coronary Intervention.

Authors:  I-Te Lee; Wayne Huey-Herng Sheu
Journal:  J Clin Med       Date:  2018-11-12       Impact factor: 4.241

5.  Association of Plasma Renalase and Left Ventricle Mass Index in Heart Failure Patients Stratified to the Category of the Ejection Fraction: A Pilot Study.

Authors:  Dijana Stojanovic; Valentina Mitic; Dejan Petrovic; Miodrag Stojanovic; Aleksandra Ignjatovic; Nikola Stefanovic; Tatjana Cvetkovic; Vladmila Bojanic; Gordana Kocic; Marina Deljanin Ilic
Journal:  Dis Markers       Date:  2019-10-14       Impact factor: 3.434

6.  Association of renalase with clinical outcomes in hospitalized patients with COVID-19.

Authors:  Basmah Safdar; Melinda Wang; Xiaojia Guo; Charles Cha; Hyung J Chun; Yanhong Deng; James Dziura; Joe M El-Khoury; Fred Gorelick; Albert I Ko; Alfred I Lee; Robert Safirstein; Michael Simonov; Bin Zhou; Gary V Desir
Journal:  PLoS One       Date:  2022-03-08       Impact factor: 3.240

7.  Rs10887800 renalase gene polymorphism is associated with an increased risk of coronary artery disease in hemodialyzed patients.

Authors:  Anna Stec; Andrzej Ksiazek; Monika Buraczynska
Journal:  Int Urol Nephrol       Date:  2016-03-29       Impact factor: 2.370

8.  Synergistic effect of renalase and chronic kidney disease on endothelin-1 in patients with coronary artery disease ‒ a cross-sectional study.

Authors:  Yu-Hsuan Li; Wayne Huey-Herng Sheu; Wen-Jane Lee; Jun -Sing Wang; Chia-Po Fu; Kae-Woei Liang; I-Te Lee
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

9.  Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study.

Authors:  Ana Cerqueira; Janete Quelhas-Santos; Inês Ferreira; Susana Sampaio; Miguel Relvas; Nídia Marques; Cláudia Camila Dias; Manuel Pestana
Journal:  Life (Basel)       Date:  2021-03-08

10.  Renalase gene Glu37Asp polymorphism affects susceptibility to diabetic retinopathy in type 2 diabetes mellitus.

Authors:  Monika Buraczynska; Karolina Gwiazda-Tyndel; Bartłomiej Drop; Wojciech Zaluska
Journal:  Acta Diabetol       Date:  2021-06-22       Impact factor: 4.280

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.